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Abstract
A sample of service providers at addictions agencies' in Ontario were interviewed by telephone to
assess attitudes toward, anticipated internal and external barriers to implementing, and expected
benefits of four harm reduction strategies: needle exchange, moderate drinking goals, methadone
treatment, and provision of free condoms to clients. Respondents were also asked to define harm
reduction, list its most important elements, and describe what they find most troubling and most
appealing about harm reduction. Attitudes toward harm reduction in general and the services
provided at each agency were also assessed. Results indicated that the service providers surveyed
had positive attitudes toward each of the four harm reduction strategies and harm reduction in
general, and the majority of respondents were aware of the benefits associated with each strategy.
Almost all of the agencies surveyed allowed for moderate drinking outcomes in the treatment of
alcohol problems, and most agencies provided free condoms to clients. In terms of barriers,
anticipated negative community reaction to needle exchange, methadone treatment, and free
condoms was a major concern for the majority of respondents. Lack of staff, of funding, or
anticipated staff resistance were also cited as potential barriers to introducing these strategies. In
the case of methadone maintenance, the unavailability of a qualified physician was listed as the
primary constraint. Implications for future efforts directed at encouraging the adoption of these
strategies and suggestions for future research are discussed.
Background
Harm reduction has been gaining popularity in North
America as an alternative to traditional means of dealing
with substance abuse. Research indicates that harm reduc-
tion strategies such as needle exchange and methadone
maintenance are associated with reductions in: drug use
[1], disease [2-4], crime [2,5] unsafe injection behaviors
[1,5], drug related deaths [2], and improvements in
employment and interpersonal relationships among IV
drug users [5].
Heather [6] suggested that strong empirical evidence dem-
onstrating the effectiveness of harm reduction is necessary
to promote its acceptance. Despite the evidence, however,
efforts to implement harm reduction strategies have met
with resistance from some health care professionals [7-9],
especially when dealing with individuals who are consid-
ered dependent on rather than just abusing drugs or alco-
hol [10]. Reasons for this resistance are varied and
multifaceted. One difficulty may be the lack of consensus
regarding what harm reduction is, exactly. Harm reduc-
tion can be defined as any effort that attempts to mini-
Published: 14 December 2006
Harm Reduction Journal 2006, 3:35 doi:10.1186/1477-7517-3-35
Received: 26 November 2004
Accepted: 14 December 2006
This article is available from: http://www.harmreductionjournal.com/content/3/1/35
© 2006 Hobden and Cunningham; licensee BioMed Central Ltd. 
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), 
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Harm Reduction Journal 2006, 3:35 http://www.harmreductionjournal.com/content/3/1/35
Page 2 of 20
(page number not for citation purposes)
mize the negative consequences associated with substance
use (either to the individual, their families, their commu-
nities, or society as a whole) without requiring the cessa-
tion of such use [5,6,10-13]. It is a set of principles that
guides the treatment of alcohol and drug problems, as
well as the development of public policy relating to drug
and alcohol use and is pragmatic, non-judgemental, and
client-centered [12,14]. It provides an alternative to the
moralistic and medical models of drug and alcohol treat-
ment, acknowledging that some individuals may be una-
ble or unwilling to refrain from use [12,14]. Some authors
maintain that safe, controlled substance use is the ulti-
mate goal of harm reduction [5,10], whereas others argue
that abstinence is a preferable goal [15,16]. In applying
harm reduction to psychotherapy, Denning [11] and
Talarsky [17] have suggested that therapeutic success be
defined not in terms of amount of drug used, but as any
behavior that results in a reduction in drug related harm.
Denning [11] has also argued that treatment programs
that require abstinence for entry and only allow absti-
nence as a treatment goal are, in themselves, harmful
because they create barriers to treatment for many individ-
uals who might otherwise be helped.
There is some evidence to suggest that attitudes toward
harm reduction among professionals in the addictions
field may vary as a function of the specific harm reduction
strategy employed and the type of service provided. For
example, attitudes toward needle exchange were found to
be favorable among physicians who treat addictions in
Rhode Island [18] and addiction treatment providers in
Ontario, Canada [7,19]. In contrast, in their survey of atti-
tudes toward moderate drinking goals among addiction
treatment providers in the United States, Rosenberg and
Davis [8] found that approximately 75% of reporting
agencies considered nonabstinance an unacceptable treat-
ment goal. However, acceptance of moderate drinking
goals varied according to type of agency. Approximately
one-half of outpatient treatment agencies considered
moderate drinking acceptable for some clients. Similar
results were reported in Rush and Ogborne's [20] survey
of treatment facilities in Ontario and Brocha's [21] survey
of private treatment facilities in Quebec. In a nationwide
survey of alcohol treatment facilities in Canada, Rosen-
berg, Devine, and Rothrock [9] found that 62% of outpa-
tient treatment facilities favored moderate drinking goals
as a treatment outcome compared to 43% of mixed inpa-
tient/outpatient agencies, 28% of inpatient/detoxifica-
tion/correctional facilities, and 18% halfway houses.
Ogborne and Birchmore-Timney [7] assessed support for
three harm reduction strategies among front line staff in
addictions treatment agencies in Ontario: nonabstinence
goals in the treatment of alcohol and drug abuse, needle
exchange, and methadone maintenance. Results indicated
that the staff at outpatient and assessment/referral centers
had more favorable attitudes toward harm reduction strat-
egies than those in other types of agencies (e.g. detoxifica-
tion, and short and long tern residential). Most workers in
all types of agencies indicated that they would consider
moderate nonabstinent goals for some clients. Needle
exchange was acceptable to a majority of workers in all
agencies types. There was little acceptance for methadone
treatment, with the exceptions of outpatient and assess-
ment/referral staff (the majority of whom were support-
ive). Similarly, in their survey of addictions treatment
providers in Ontario, Ogborne, Wild, Braum, & Newton-
Taylor [19] found little support for methadone treatment
overall, although support was higher among outpatient
and assessment/referral agencies than residential agen-
cies.
According to dissemination researchers, attitudes are only
one component in determining whether a new strategy or
technology will be adopted [22-24]. Professionals in a
given field are not always familiar with the scientific liter-
ature describing new methodologies [25-27]. Further, the
adoption of any new policy or treatment methodology
may be hampered by lack of perceived need, anticipated
community resistance, a lack of resources, etc. Rogers [28]
identified five stages involved in the processes underlying
the adoption of a new technology: knowledge (a basic
understanding of the process), persuasion (attitudes),
decision (the choice to adopt or reject the innovation),
implementation (putting it into practice), and confirma-
tion (evaluating the results of the decision).
The present research was designed to provide an under-
standing of attitudes toward harm reduction among serv-
ice providers and the factors influencing agencies'
decision to adopt or reject these strategies. Managers and
therapists from outpatient and assessment/referral agen-
cies in Ontario were surveyed by telephone. Managers and
therapists were chosen as potential respondents because it
was assumed at that they would be most aware of their
respective agencies' policies and practices regarding the
treatment of addictions. Attitudes toward four harm
reduction strategies were assessed, as were reasons for
accepting or rejecting each of these strategies, internal and
external resistance/barriers to introducing them, antici-
pated benefits of each, reasons for introducing each, and
resistance encountered as a result of implementing each.
Respondents' own attitudes as well as their estimate of
their colleagues' and communities' attitudes toward each
strategy were also assessed.
As mentioned previously, there is some disagreement
among researchers and theorists concerning the definition
of harm reduction. Therefore, respondents were asked to
define harm reduction, indicate what elements they con-
Harm Reduction Journal 2006, 3:35 http://www.harmreductionjournal.com/content/3/1/35
Page 3 of 20
(page number not for citation purposes)
sider most important for it, what they find most appealing
about it, and what they find most troubling. Finally, their
attitude toward harm reduction, in general, was assessed
by asking: "how would you feel about helping some alco-
hol and drug abusers use substances more safety without
necessarily reducing the use of these substances?"
Method
Materials
A telephone survey explored attitudes toward and use of
four harm reduction strategies (needle exchange, moder-
ate drinking goals, methadone treatment, and provision
of free condoms to clients). Respondents were asked
whether the agency employed the strategy; if not, had they
considered it, what the internal and external barriers were,
and what benefits would they expect. If the strategy was
employed at the agency in question respondents were
asked why it was introduced, if there was any internal or
external resistance, and, if so, how it was dealt with. Also,
each respondent was asked to rate on an 11-point scale (0
= very unfavorable, 10 = very favorable) how they felt
about each of the four strategies, how they thought other
therapists at their facility felt, and how they thought their
community would feel. Five questions dealt with more
general attitudes toward harm reduction. Respondents
were asked to define it, indicate the most important ele-
ments of harm reduction, and state what it is they find
most appealing and troubling about harm reduction.
Finally, we wanted to get a measure of respondents' over-
all attitudes toward harm reduction as it is most com-
monly defined in the literature: as any effort that
minimizes the negative consequences associated with
substance use without necessarily attempting to reduce or
eliminate such use. Therefore, the final question asked
respondents to rate on an 11-point scale (0 = very unfavo-
rable, 10 = very favorable) how they would feel about
helping some alcohol and drug abusers use substances
more safety without necessarily reducing the use of these
substances.
Data collection and survey construction
Data collection took place in two phases. A list of outpa-
tient and assessment/referral agencies in Ontario was
obtained from the Drug and Alcohol Registry of Treat-
ment (DART). Each agency was assigned a number. In
each of the two phases of data collection, agencies were
randomly selected using a random numbers table. Agen-
cies used in the first phase of data collection were
exempted from selection in the second phase.
The purpose of the first phase was to develop response cat-
egories to the 43 open-ended questions described above.
Twenty-two agencies (12 outpatient and 10 assessment/
referral) were selected. Managers of each agency were con-
tacted by telephone and asked if they would be willing to
participate in a survey of attitudes toward and support for
a number of harm reduction strategies. One manager
declined. Each manager was asked to suggest a therapist at
his/her agency who could also complete the survey. Sev-
enteen therapists were contacted for the survey, the
remaining 4 therapists were either unavailable or could
not be reached.
All 38 interviews were tape recorded with permission of
the respondents. Recordings of each interview were
reviewed and responses to each of the open-ended ques-
tions were summarized. Commonalities among responses
were noted and compiled to form a set of common
responses that were used as a basis for constructing
response categories for each question.
This semi-structured survey was administered to respond-
ents in the second phase of data collection. The response
categories were used as a guideline for coding responses to
each question, but questions were still administered in an
open-ended format. In cases where respondents' answers
did not fit into any of the response categories, the
response was coded as "other." Managers from 22 ran-
domly selected agencies (8 outpatient and 14 assessment/
referral) were contacted by telephone and details of their
responses were noted. Managers from three agencies
declined. All managers were asked to suggest a therapist
from their agency who could also be surveyed. Ten thera-
pists were contacted for the survey. The remaining nine
therapists were either unavailable or could not be reached.
Results
Managers' and therapists' open-ended responses from the
first phase of data collection were recoded into the
response categories used in the second phase. Responses
from both phases of data collection were combined for
analysis. Also, a comparison of means indicated that there
were no differences between therapists and managers
responses. Therefore, results from all 67 respondents (40
managers and 27 therapists) were aggregated and sum-
mary statistics were calculated for each item on the survey.
For those items asking whether an agency employed or
had considered introducing a program, only managers'
responses are reported. We assumed that agency managers
would be responsible for making policy decision regard-
ing treatment and would most likely reflect agency policy.
Needle exchange
Responses to items concerning needle exchange are pre-
sented in Table 1. Of the agencies surveyed, 12.5% had a
needle exchange program. Of these agencies, four of the
eight respondents indicated it was introduced to reduce
the spread of HIV and other STDs. Four respondents indi-
cated that some community resistance had been encoun-
tered. Of those agencies not using needle exchange, 34.0%
Harm Reduction Journal 2006, 3:35 http://www.harmreductionjournal.com/content/3/1/35
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had considered it. Reasons for not implementing such a
program included: little or no perceived demand (19.0%),
the service was already provided locally (19.0%), and the
agency was considering it at that time (42.9%). Antici-
pated internal obstacles to needle exchange included: lit-
tle or no perceived demand (22.0%), lack of staff
(13.6%), and lack of funding (11.9%).
In terms of external barriers to needle exchange, most
respondents were concerned about community resistance
(52.5%) and some felt that a needle exchange program
would be seen as promoting drug use (20.3%). When
asked about expected benefits, most respondents recog-
nized that needle exchange would reduce the spread of
HIV and other STDs (59.3%) and many believed it would
encourage IV drug users to seek counselling (28.8%).
Moderate drinking goals
Responses to items concerning moderate drinking goals
are presented in Table 2. Ninety-five percent of agencies
surveyed allowed for moderate drinking outcomes in the
treatment of alcohol problems. The two agencies that
allowed only abstinent outcomes had considered moder-
ation goals. Most respondents indicated that moderate
drinking goals were introduced due to client demand
(40.3%) or because it was appropriate for some clients
(38.7%). Some respondents indicated that for certain cli-
ents abstinence was an unrealistic goal (17.7%). When
queried as to what, if any, resistance had been encoun-
tered, 21% of respondents indicated they had encoun-
tered resistance from other agencies, 21% from the AA
community, and 11.3% from the staff. Typically this was
dealt with through education/information (57.1%).
Methadone maintenance
Only 10% of agencies surveyed had a methadone mainte-
nance program (see Table 3). Of those agencies without a
methadone program, 44% had considered implementing
one. The most frequently cited reason for not introducing
methadone was the unavailability of a physician to
administer it (42.9%). Anticipated internal barriers
included: the unavailability of a physician (32.3%), little
or no perceived need (27.4%), lack of staff (17.7%), lack
of funding (11.3%), and staff resistance (11.3%). Some
respondents felt that a methadone program would be
inappropriate at their agency because they were not a
medical facility (11.3%). When asked about obstacles
external to the agency, most respondents expressed con-
cern about community resistance (59.7%). In terms of
expected benefits, many respondents indicated that meth-
adone treatment improves health and reduces disease in
IV drug users (33.9%), is an effective means of getting her-
oin addicts off heroin (29.0%), results in decreased crim-
inal activity (25.8%), and gives IV drug users access to
counselling (12.9%).
Provision of free condoms to clients
Responses to the survey indicated that most agencies
(67.5%) make free condoms available to their clients (see
Table 4). Of the 13 agencies where free condoms were not
provided, four had considered making them available.
Results indicated little concern regarding internal obsta-
cles to providing condoms, but many respondents
expressed concerns about negative community reactions
(66.7%). Most respondents acknowledged that condoms
are an effective means of reducing transmission of HIV
and other STDs (81.0%). Respondents at agencies that
provide free condoms indicated that the measure was
introduced primarily as a means of reducing HIV/STD
transmission (58.7%). Interestingly, 75.5% of these
respondents indicated that no resistance was encountered
to the introduction of this measure.
Attitudes toward the four harm reduction strategies
In order to determine whether respondents' attitudes var-
ied by type of agency (outpatient versus assessment/refer-
ral), separate MANOVAs were performed on respondents'
assessments of their own, their colleagues', and their com-
munities' attitudes toward each of the four harm reduc-
tion strategies. Significant univariate ANOVAs were
examined subsequently. The only significant difference
found by agency type was in respondents' perceptions of
their communities' feelings about nonabstinence as a
treatment goal. Respondents from outpatient facilities
perceived that their community would be significantly
less accepting of moderate drinking outcomes (x = 5.76)
than their counterparts in assessment/referral agencies (x
= 6.75), F(1, 50) = 4.79. No other differences by agency
type were found.
Repeated measures analysis of variance (ANOVA) and
paired t-tests were used to compare respondents' attitudes
toward each of the four harm reduction strategies to their
estimates of their colleagues' and communities' attitudes.
Results are presented in Table 5. Respondents reported
positive attitudes toward needle exchange (x = 9.03), but
felt their colleagues (x = 8.43), and their community
would be less favorable (x = 4.90), t(59) = 4.87, p < .01
and t(54) = 12.72, respectively, F(2,48) = 91.31, p < .01.
Mean attitudes toward moderate drinking goals were also
positive (x = 9.04), but respondents expected their col-
leagues (x = 8.60), and community would be compara-
tively less favorable (x = 5.97), t(61) = 3.10, p < .01 and
t(53) = 13.10, respectively, F(2,49) = 102.44, p < .01.
Respondents were accepting of methadone treatment (x =
8.19), but felt that their colleagues (x = 7.81), and com-
munity (x = 4.79) held comparatively less favorable atti-
tudes, t(54) = 3.08, p < .01 and t(49) = 11.02, respectively,
F(2,42) = 54.24, p < .001. Finally, respondents' attitudes
toward the provision of free condoms to clients were favo-
rable (x = 9.46), as were estimates of their colleagues' atti-
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Table 1: Frequencies of Responses to Questions on Needle Exchange
Item N %
Agencies currently offering needle exchange (n = 40 agencies) 5 12.5
Agencies that considered offering it 12 34
Considered it, but decided against it because (n = 21 respondents)
Little/no perceived need/demand 4 19.0
service already provided locally 4 19.0
staff resistance 1 4.8
anticipated community opposition 3 14.3
Lack of funding 2 9.5
presently being considered 2 9.5
Don't know 9 42.9
Other 3 14.3
In agencies not offering needle exchange (n = 59 respondents)
Intra-agency obstacles
Little/no perceived need/demand 12 22.0
Lack of medical staff 5 8.5
Lack of funding 7 11.9
service already provided locally 6 10.2
staff resistance 3 5.1
contravenes agency's policy/philosophy 2 3.4
outside mandate/not a medical facility 5 8.5
Lack of staff 8 13.6
Don't know 1 1.7
Other 27 45.8
None 8 13.6
Extra-agency obstacles
community resistance/opposition 31 52.5
resistance/opposition from other agencies 3 5.1
Lack of local political support 3 5.1
funding 2 3.4
it would be seen as a duplication of services 1 1.7
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May be seen as promoting drug use. 12 20.3
Don't know 2 3.4
Other 6 10.2
None 8 13.6
Expected benefits of needle exchange
None 3 5.1
reduction in HIV/STDs 35 59.3
might encourage IV drug users to seek counseling 17 28.8
community safety 7 11.9
greater accessibility/convenience for IV drug users 7 11.9
fallows for greater openness about drug use 3 5.1
Don't know 3 5.1
Other 25 42.4
For agencies that offer needle exchange (n = 8)
Reasons for introducing it
Reduce the spread of HIV/STDs 4 50.0
urged to by AIDS committee/Ministry/other agencies 1 12.5
funding was made available 1 12.5
Other 4 50.0
Resistance encountered
None 5 62.5
From the staff 1 12.5
From the Board 1 12.5
From the general community 4 50.0
How was it dealt with?
negotiation/conciliation 1 12.5
through education/information 1 12.5
Don't know 1 12.5
Other 1 12.5
Table 1: Frequencies of Responses to Questions on Needle Exchange (Continued)
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Table 2: Frequencies of Responses to Questions on Moderate Drinking Goals
Item N %
Agencies currently offering moderate drinking goals (n = 40 agencies) 38 95.0
Agencies that considered offering moderate drinking goals 1 2.5
Considered it, but decided against it because (n = 2 respondents)
staff resistance 1 50.0
Other 1 50.0
For agencies not offering moderate drinking goals (n = 5 respondents)
Intra-agency obstacles
not appropriate for their clients 2 40.0
staff resistance 1 20.0
Other 1 20.0
Extra-agency obstacles
community resistance/opposition 1 20.0
Other 1 20.0
None 1 20.0
Expected benefits of offering moderate drinking goals
some clients find it more appealing than abstinence goals 1 20.0
None 1 20.0
For agencies that offer moderate drinking goals (n = 62 respondents)
Reasons for introducing it
its appropriate for some clients 24 38.7
abstinence is an unrealistic goal for some clients 11 17.7
client demand 25 40.3
empirical evidence supports it 9 14.5
political pressure from outside the agency 1 1.8
harm reduction 7 11.3
Don't know 4 6.5
Other 30 48.4
Resistance encountered
a) none 27 43.5
b) from the staff 7 11.3
c) from the Board 5 8.1
d) from the general community 11 17.7
e) from the AA community 13 21.0
f) from other addiction agencies 13 21.0
g) don't know 1 1.6
h) other 6 9.7
How was it dealt with? (n = 35)
a) ignored it 3 8.6
b) gave people time to accept it 7 20.0
c) through education/information 20 57.1
d) ran an active PR campaign 1 2.9
e) don't know 1 2.9
f) other 13 37.1
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Table 3: Frequencies of Responses to Questions on Methadone Treatment
Item N %
Agencies that have it (n = 40) 4 10.0
Agencies that have considered it (n = 40) 16 44.0
Considered, but not implemented because (n = 21 respondents)
Little/no perceived need 6 28.6
unavailability of a physician willing/able to dispense it 9 42.9
anticipated negative reaction from clientele 1 4.8
Lack of facilities 1 4.8
Lack of funding 2 9.5
prospect of setting up program too daunting 2 9.5
presently being considered 3 14.3
Other 4 19.0
Agencies that do not have a methadone program (n = 62 respondents)
Intra-agency obstacles
Little/no perceived need 17 27.4
unavailability of a physician willing/able to dispense it 20 32.3
Lack of facilities 2 3.2
Lack of funding 7 11.3
not a medical facility/outside agency's mandate 7 11.3
anticipated resistance from the staff 7 11.3
May be some resistance from the Board 5 8.1
Don't know 2 3.2
Other 17 27.4
None 4 6.5
Lack of staff 11 17.7
Extra-agency obstacles
None 12 19.4
community resistance 37 59.7
resistance from other agencies 2 3.2
service already provided locally 2 3.2
Don't know 4 6.5
Other 11 17.7
Expected benefits
None 3 4.8
improved health/disease reduction 21 33.9
enables clients to be more productive 10 16.1
decreased criminal activity 16 25.8
gives drug users access to counseling 8 12.9
enables addicts to get off heroin 18 29.0
Don't know 4 6.5
Other 18 29.0
For agencies who offer methadone (n = 5 respondents)
Reasons for introducing it.
perceived need 2 40.0
urged to do so by the Ministry of Health/other agencies 1 20.0
Other 3 60.0
Resistance encountered
None 2 40.0
From the staff 2 40.0
From the community 2 40.0
How was it dealt with?
through education/information 2 40.0
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Table 4: Provision of free condoms
Item N %
Agencies that offer them (n = 40) 27 67.5
Agencies that have considered it (n = 40) 4 10.0
Considered, but not implemented because (n = 5 respondents)
resistance from the staff 1 20.0
resistance from the Board 1 20.0
felt it was inappropriate for clientele 1 20.0
it contravenes agency policy/philosophy 1 20.0
Don't know 1 20.0
Other 2 40.0
Agencies that do provide free condoms (n = 21 respondents)
Intra-agency obstacles
None 5 23.8
staff resistance 3 14.3
resistance from the Board 2 9.5
concerns about negative community reactions 2 9.5
Lack of funding 3 14.3
Other 10 47.6
Extra-agency obstacles
None 5 23.8
community resistance 14 66.7
Don't know 1 4.8
Other 3 14.3
Expected benefits
reduction in STDs/AIDS 17 81.0
reduction in unwanted pregnancy 10 47.6
opportunity to provide information/education 6 28.6
Other 3 14.3
For agencies that offer free condoms (n = 46)
Reasons for offering them
to reduce HIV/STDs 27 58.7
to reduce unwanted pregnancy 9 19.6
to provide information/education 7 15.2
funding was made available 2 4.3
urged to do so by the Ministry of Health/other agencies 3 6.5
Don't know 7 15.2
Other 20 43.5
Resistance encountered
None 34 73.9
From the staff 3 6.5
From the community 5 10.9
From other agencies 1 2.2
Don't know 2 4.5
Other 2 4.5
How was it dealt with? (n = 11)
ignored it 1 9.1
gave people time to accept it 2 18.2
through education/information 4 36.4
Other 2 18.2
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tudes (x = 9.39). However, respondents' anticipated that
members of their community would be comparably less
favorable (x = 6.51), t(56) = 11.64, p < .01, F(2,51) =
57.04, p < .001.
Harm reduction
Frequency and mean responses to the five more general
attitude questions concerning harm reduction are pre-
sented in Table 6.
Definition
Results indicated that there was little agreement concern-
ing what harm reduction actually is. Most responses
(53.7%) fell into the "other" category (e.g., "It's making
wise personal choices based on available information,"
"Awareness and knowledge," "An attitude set"). Only
23.9% of respondents defined harm reduction as reducing
the harm associated with substance use without necessary
reducing the use of that substance.
Most important elements, appealing features, and troubling aspects
Features most commonly cited as important elements of
harm reduction were: increasing client awareness/educa-
tion (19.4%) and client choice (16.4%). Features listed as
most appealing aspects of harm reduction included such
things as: it gives clients choice (23.9%), it's client-centred
(20.9%), and it's non-judgemental (19.4%). The most
troubling aspect of harm reduction given was that it is not
in the best interest of all clients (20.9%) and is often mis-
understood and/or misapplied (20.9%).
Overall attitude toward harm reduction
Respondents were asked to rate how they would feel
about helping some alcohol and drug abusers use sub-
stances more safety without necessarily reducing the use
of these substances. The mean response to this question
was positive (x = 8.49), suggesting service providers have
favorable attitudes toward harm reduction in general. A
one-way ANOVA on overall attitudes toward harm reduc-
tion in general failed to find significant differences by
agency type.
Discussion
Responses to questions concerning needle exchange indi-
cated that only a small percentage of agencies surveyed
offered this service. Almost half of those agencies not
offering a needle exchange program were considering
introducing one at the time of this survey. When asked
about expected benefits, the majority of respondents rec-
ognized that needle exchange is an effective way of reduc-
ing the spread of HIV and other STDs. The most
commonly cited barrier was anticipated community
resistance. More than half the respondents indicated they
would expect a negative response from their local com-
munities. In addition, for some agencies, lack of staff and
funding were also a concern.
Almost all agencies surveyed offered moderate drinking
goals as a treatment option for some individuals with
alcohol problems. The most frequently cited reasons for
introducing such goals were client demand and the belief
that nonabstinence is an appropriate treatment goal for
certain clients. Some respondents indicated that they had
encountered resistance to moderate drinking goals from
the AA community and other agencies, but that this was
dealt with effectively through education and dialogue.
Only a few agencies surveyed offered a methadone treat-
ment program, but close to half had considered imple-
menting one. The most commonly cited reason for not
Table 5: Mean responses to attitude measures (n = 67)
Item Mean
How do you feel about providing clean needles to drug users? 9.03
How do you think other therapists at your agency feel (about needle exchange)? 8.42
How do you think (needle exchange) would be viewed by your community? 4.90
How do you feel about nonabstinence as a treatment goal for some clients? 9.04
How do you think other therapists at your agency feel (about nonabstinence)? 8.60
How do you think (nonabstinence) would be viewed by your community? 5.97
How do you feel about offering methadone treatment as a treatment option? 8.19
How do you think other therapists at your facility feel (about methadone)? 7.81
How do you think methadone treatment would be viewed by your community? 4.79
How do you feel about providing free condoms to clients in treatment facilities? 9.46
How do you think other therapists at your facility feel (about providing free condoms)? 9.39
How do you think providing free condoms would be viewed by your community? 6.51
Scores range from 0 to 10 with higher scores indicating more positive attitudes.
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offering methadone was the inability to find a physician
qualified and/or willing to administer it. Approximately
one-third of respondents indicated that there was little or
no perceived need for such a program in their community.
The majority of respondents felt that their communities
would respond negatively to the introduction of a metha-
Table 6: General harm reduction questions (n = 67)
Item N %
Definitions of harm reduction
reducing harm from substance use I incurred by the individual by reducing or eliminating the use of that substance 3 4.5
reducing the harm from substance use incurred by the individual and reducing their use of that substance 6 9.0
reducing the harm from substance use incurred by the individual without necessarily reducing their use of that substance 16 23.9
reducing the harm associated with substance use to the community or society as a whole 8 11.9
don't know 3 4.5
Other 36 53.7
reducing the harm associated with substance use 7 10.4
Most important elements of harm reduction
disease reduction 4 6.0
empowering the client 7 10.4
improving the quality of life of client 4 6.0
reducing negative consequences associated with drug/alcohol use 1 1.5
flexibility/options 7 10.4
education/awareness on the part of the client 13 19.4
education/awareness on the part of the community 8 11.9
client choice 11 16.4
empathy 5 7.5
accurate assessment 2 3.0
don't know 3 4.5
Other 40 59.7
Most appealing aspects of harm reduction
disease reduction 6 9.0
reduced health costs 2 3.0
May provide a gateway/bridge into treatment 6 9.0
it's more palatable to clients than abstinence 6 9.0
client choice 16 23.9
it's nonjudgmental 13 19.4
it's client centered 14 20.9
it's appropriate for some clients 3 4.5
it's pragmatic/practical 9 13.4
it provides flexibility/options 7 10.4
it empowers the client 8 11.9
don't know 1 1.5
Other 24 35.8
Most troubling aspects of harm reduction
it's not appropriate for or in the best interest of all clients 14 20.9
it's often misunderstood and misapplied 14 20.9
it creates moral and ethical dilemmas for the community 2 3.0
it creates moral and ethical dilemmas for the therapist 8 11.9
negative public attitudes 4 6.0
it's difficult to use illicit drugs safely 2 3.0
abstinence is better 7 10.4
harm reduction should be accompanied by counseling 2 3.0
don't know 2 3.0
Other 38 56.7
Mean
On a scale from 0 to 10 with 0 = "not at all favorable" and 10 = "extremely favorable," how would you feel about helping some 
alcohol/drug abusers use substances more safely without necessarily trying to reduce their use of these substances?
6.51
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done program. Some respondents were concerned about
lack of staff and staff resistance. Approximately one-third
of respondents recognized that methadone treatment
reduces the incidence of disease and improves the health
of IV drug users, while providing an effective means of
treating opiate addiction. Many respondents also
acknowledged that methadone treatment programs con-
tribute to a reduction in criminal activity.
Responses concerning provision of free condoms to cli-
ents indicated that approximately two-thirds of agencies
surveyed already offered this service. For those agencies
not offering free condoms, concerns about negative com-
munity reaction were the most commonly cited barrier,
although most of these respondents acknowledged that
providing free condoms would be an effective way of
reducing the transmission of HIV and other STDs. For
those agencies providing free condoms, the majority of
respondents indicated that the service was implemented
as a means of reducing the spread of HIV/STDs. Interest-
ingly, 75% of these agencies reported no community
resistance.
Results from our attitudinal measures parallel those of
Ogborne et al. [19] and Rush and Ogborne [20]. Respond-
ents held positive attitudes toward needle exchange, mod-
erate drinking goals, methadone maintenance, and
provision of free condoms. The attitudes of treatment pro-
viders in Canada stand in stark contrast to those in the
United States, where attitudes towards moderate drinking
outcomes tend to be negative [8]. The exact reasons for
this difference is a topic for future research, but may be
related to differences in values and attitudes between the
two nations. A comparison of attitudes toward alcohol
and drug use across several nations [29] found that
respondents in the US had more of a moralistic or "tem-
perance mentality" towards alcohol and drug use than
those in Canada.
One interesting finding was the disparity between
respondents' self-reported attitudes toward each of the
harm reduction strategies and their estimates of their col-
leagues' and communities' attitudes. For three of the four
harm reduction strategies respondents assumed both their
colleagues and their communities held more negative atti-
tudes than they did. Only in the case of providing free
condoms to clients did respondents assume that their col-
leagues would be equally favorable, but still believed their
communities would be significantly less favorable. One
wonders at the source of this perception. Perhaps
respondents were disowning their own misgivings about
these strategies and projecting them onto their colleagues
and neighbours. Equally plausible, respondents may have
conceptualized themselves as unusually progressive com-
pared to their colleagues and community members. It is
unlikely, however, that in the course of our survey we just
happened across the one person in each agency who was
most in favor of harm reduction. Whatever the reason for
these perceptions, greater communication both within
agencies and between agencies and communities might
help treatment providers recognize that they are not alone
in their convictions.
Our results found little agreement among service provid-
ers as to what harm reduction is. The majority of defini-
tions given did not fall into any of the five categories we
had listed. Further, there was little consensus concerning
what constitutes the core elements of harm reduction.
This apparent confusion in the field may undermine
attempts to promote harm reduction as a distinct para-
digm and may complicate efforts to measure attitudes and
rate of adoption of these policies.
In terms of Rogers' [29] dissemination model, our find-
ings suggest that the greatest impediments to adoption of
these harm reduction strategies in Ontario have to do with
issues of implementation, resources, and motivation,
rather than with knowledge or attitudes. Factors such as
anticipated negative community reactions as well as fund-
ing and staffing concerns were cited most often as barriers
to implementing these strategies. These findings suggests
that future efforts to promote harm reduction need to
focus, not on persuasion, but on addressing service pro-
viders' specific concerns regarding community reactions
and agency resources.
It is possible that responses to this survey were influenced
by social desirability concerns. In an effort to counteract
such concerns, respondents were assured that all
responses would be confidential and that respective agen-
cies would not be cited in any publication of this data.
Also, the results of this study are limited to the population
sampled (i.e., managers and therapists of outpatient treat-
ment and assessment referral centres in Ontario). One
possible direction for future research would be to sample
more broadly treatment providers across Canada to see if
these results generalize to treatment providers in other
provinces. Additionally, it would be interesting to survey
public opinion toward harm reduction strategies in either
nation in an effort to determine the accuracy of our
respondents' expectations that their communities' atti-
tudes would be more negative than their own. Results of
such research may help to either allay concerns about neg-
ative community reactions on the part of addiction treat-
ment providers or alert them to this potential barrier so
that strategies can be developed for dealing with it.
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Appendix A
Harm reduction survey
Needle exchange
1. Does your agency currently have a needle exchange pro-
gram?
Y (go to Q7) N (go to Q2.)
2. Has your agency considered implementing a needle
exchange program?
Y (go to Q3) N (go to Q4)
3. Why was it not implemented?
a) Little/no perceived need/demand
b) Service already provided locally
c) Staff resistance
d) Anticipated community opposition
e) Anticipated negative client reaction
f) Lack of funding
g) Presently being considered
h) Don't know
I) Other
4. What are the internal barriers to implementing needle
exchange?
a) Little/no perceived need/demand
b) Lack of medical staff
c) Lack of funding
d) Service already provided locally
e) Staff resistance
f) Contravenes agency's policy/philosophy
g) Outside mandate/not a medical facility
h) Don't know
I) Other
j) Lack of staff
k) None
5. What are the external barriers?
a) Community resistance/opposition
b) Resistance/opposition from other agencies
c) Lack of local political support
d) Funding
e) It would be seen as a duplication of services
f) May be seen as promoting drug use.
g) Don't know
h) Other
I) None
6. What benefits would you expect from needle exchange
a) None
b) Reduction in HIV/STDs
c) Might encourage IV drug users to seek counselling
d) Community safety
e) Greater accessibility/convenience for IV drug users
f) Allows for greater openness about drug use
g) Don't know
h) Other
Agencies that have needle exchange (Q7–9)
7. Why was it introduced? (Check all that apply)
a) Reduce the spread of HIV/STDs
b) Urged to by AIDS committee/Ministry/Other agencies
c) Funding was made available
d) Don't know
e) Other
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8. Was there any internal or external resistance encoun-
tered? (Check all that apply)
a) None
b) From the staff
c) From the Board
d) From the general community
e) From the AA community
f) From other addiction agencies
g) Don't know
h) Other
9. How was it dealt with? (Check all that apply)
a) Ignored it
b) Negotiation/conciliation
c) Gave people time to accept it
d) Through education/information
e) Ran an active PR campaign
f) Don't know
g) Other
All agencies (Q10–12)
10. How do you feel about providing clean needles to
drug users on a scale of 0 to 10 (where 0 = "not at all favo-
rable" and 10 = "extremely favorable")?
11. Using the same scale, how do you think other thera-
pists at your agency feel about needle exchange (0 = "not
at all favorable" and 10 = "extremely favorable")?
12. How do you think needle exchange would be viewed
by your community (0 = "not at all favorable" and 10 =
"extremely favorable")?
Moderate drinking goals
13. Does your agency allow for moderate drinking goals
the treatment of alcohol problems? Y(go to Q19) N (go to
Q14)
14. Have you considered it? Y (go to Q15) N (go to Q16)
15. Why was it not adopted? (Check all that apply)
a) Not appropriate for their clientele
b) Little/no perceived need/demand
c) The service already provided locally
d) Staff resistance
e) Anticipated opposition from community
f) Anticipated negative client reaction
g) Lack of funding
h) Presently being considered
I) Don't know
j) Other
16. What are the internal barriers to moderate drinking
goals? (Check all that apply)
a) Not appropriate for their clientele
b) Staff resistance
c) Resistance from the Board
d) Contravenes agency's policy/philosophy
e) Don't know
f) Other
g) None
17. What are the external barriers? (Check all that apply)
a) Community resistance/opposition
b) Resistance/opposition from other addiction agencies
c) Negative reaction from the AA community
d) Don't know
f) Other
g) None
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18. What benefits would you expect from offering moder-
ate drinking goals as a treatment outcome? (Check all that
apply)
a) Some clients find it more palatable/appealing than
abstinence
b) It is appropriate for some clients
c) Flexibility/options
d) Don't know
e) Other
f) None
For agencies that allow for moderate drinking outcomes
(Q19–22)
19. Why were moderate drinking goals adopted as a treat-
ment outcome? (Check all that apply)
a) It's appropriate for some clients
b) Abstinence unrealistic goal for some clients
c) Client demand
d) Empirical evidence supports it
e) Political pressure from outside the agency
f) Harm reduction
g) Don't know
h) Other
20. Was there any internal or external resistance encoun-
tered? (Check all that apply)
a) None
b) From the staff
c) From the Board
d) From the general community
e) From the AA community
f) From other addiction agencies
g) Don't know
h) Other
21. How was it dealt with?
a) Ignored it
b) Gave people time to accept it
c) Through education/information
d) Ran an active PR campaign
e) Don't know
f) Other
All agencies (Q22–26)
22. How do you feel about nonabstinance as a treatment
goal for some clients on a scale of 0 to 10 (where 0 = "not
at all favorable" and 10 = "extremely favorable")?
23. Using the same scale, how do you think other thera-
pists at your agency feel (0 = "not at all favorable" and 10
= "extremely favorable")?
24. How do you think nonabstinance goals would be
viewed by your community (0 = "not at all favorable" and
10 = "extremely favorable?
25. Agency's policy regarding clients who fail to remain
abstinent while in a treatment program
a) Discharged completely
b) Asked to leave for a period of time
c) Allowed to stay in treatment, reasons for Relapse
explored
d) Allowed to stay in treatment, goals Reassessed
e) Don't know
f) Other
g) Allowed to stay in treatment/continue to Work with
them
26. Type of treatment offered by agency.
a) 12 step/spiritual
b) CBT
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c) GSC
d) SRP
e) Motivational interviewing
f) transtheoretical/Stages of Change
g) Systems approach
h) Client-centred/Rogerian
I) Solution-focused
j) Brief intervention
k) Don't know
l) Other
Methadone maintenance
27. Does your agency have a methadone maintenance
program?
Y (go to Q33) N (go to Q2)
28. Have you considered it? Y (go to Q29) N (go to Q30)
29. Why was it not implemented?
a) Little/no perceived need
b) Unavailability of a physician willing/able to dispense it
c) Anticipated negative reaction from clientele
c) Anticipated negative reaction from staff
d) e) Anticipated negative reaction from Board
e) f) Lack of facilities
f) Lack of funding
g) h) Prospect of setting up
Program too daunting
I) Presently being considered
j) Don't know
k) Other
30. What internal barriers where there to introducing a
methadone maintenance program?
a) Little/no perceived need
b) b) Unavailability of a physician willing/able to dis-
pense it
c) Lack of facilities
d) Lack of funding
e) Not a medical facility/outside agency's mandate
f) Anticipated resistance from the staff
g) May be some resistance from the Board
h) May be some resistance from clientele
I) Don't know
j) Other
k) None
l) Lack of staff
31. What external barriers were there?
a) None
b) Community resistance
c) Resistance from other agencies
d) Service already provided locally
e) Don't know
f) Other
32. What benefits would you expect from methadone
maintenance?
a) None
b) Improved health/disease reduction
c) Enables clients to be more productive
d) Decreased criminal activity
e) Gives drug users access to counselling
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f) Enables addicts to get off heroin
g) Don't know
h) Other
For agencies that offer methadone only (Q33–35)
33. What were your reasons for introducing a methadone
maintenance program?
a) Perceived need
b) Funding was made available
c) Urged to do so by the Ministry of Health/Other agen-
cies
d) Don't know
e) Other
34. Did you encounter any internal or external resistance?
a) None
b) From the staff
c) From the Board
d) From the community
e) From other addiction agencies
f) Don't know
g) Other
35. How was it dealt with?
a) Ignored it
b) Gave people time to accept it
c) Through education/information
d) Ran an active PR campaign
e) Don't know
f) Other
All agencies (Q36–38)
36. How do you feel about offering methadone treatment
as a treatment option on a scale from 0 to 10 where 0 =
"not at all favorable" and 10 = "extremely favorable"?
37. How do you think other therapists at your facility feel
about methadone (0 = "not at all favorable" and 10 =
"extremely favorable")?
38. How do you think methadone treatment would be
viewed by your community (0 = "not at all favorable" and
10 = "extremely favorable")?
Provision of free condoms
39. Does your agency provide free condoms to clients?
Y (go to Q45) N (go to Q40)
40. Have you ever considered it? Y (got to Q41) N (go to
Q42)
41. Why was it not implemented?
a) Resistance from the staff
b) Resistance from the Board
c) Fear of negative community reaction
d) Felt it was inappropriate for clientele
e) It contravenes agency policy/philosophy
f) Don't know
g) Other
42. What external barriers were there to offering free con-
doms to clients?
a) None
b) Staff resistance
c) Resistance from the Board
d) Concerns about negative reactions from clients
e) Concerns about negative community reactions
f) Lack of funding
g) Don't know
h) Other
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43. What external barriers were there?
a) None
b) Community resistance
c) Opposition from other agencies
d) Don't know
e) Other
44. What benefits would you expect from offering free
condoms to clients?
a) Reduction in STDs/AIDS
b) Reduction in unwanted pregnancy
c) Opportunity to provide Information/education
d) Don't know
d) Other
For agencies that offer methadone (Q 45–47)
45. Reasons for offering them
a) To reduce HIV/STDs
b) To reduce unwanted pregnancy
c) To provide information/education
d) Funding was made available
e) Urged to do so by the Ministry Of Health/other agen-
cies
f) Don't know
g) Other
46. Did you encounter any internal or external resistance?
a) None (go to Q47)
b) From the staff
c) From the Board
d) From the community
e) From other agencies
f) Don't know
h) Other
47. How was it dealt with?
a) Ignored it
b) Gave people time to accept it
c) Through education/information
d) Ran an active PR campaign
e) Don't know
f) Other
All agencies (Q48–55)
48. How do you feel about providing free condoms to?
Clients on a scale from 0 to 10 with 0 = "not at all favora-
ble" and 10 = "extremely favorable"?
49. How do you think other therapists at your facility feel
about providing free condoms (0 = "not at all favorable"
and 10 = "extremely favorable")?
50. How do you think providing free condoms would be
viewed by your community 0 = "not at all favorable" and
10 = "extremely favorable"?
General harm reduction questions
51. Definitions of harm reduction
a) Reducing harm from substance use incurred by the
individual by reducing or eliminating the use of that sub-
stance
b) Reducing the harm from substance use incurred by the
individual and reducing their use of that substance
c) Reducing the harm from substance use incurred by the
individual without necessarily reducing their use of that
substance
d) Reducing the harm associated with substance use to the
community or society as a whole.
e) Don't know
f) Other
g) Reducing the harm associated with substance use
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52. Most important elements of harm reduction
a) Disease reduction
b) Empowering the client
c) Improving the quality of life of client
d) Reducing negative consequences associated with drug/
alcohol use
e) Flexibility/options
f) Education/awareness on the part of the client
g) Education/awareness on the part of the community
h) Client choice
i) Empathy
j) Accurate assessment
k) Don't know
l) Other
53. Most appealing aspects of harm reduction.
a) Disease reduction
b) Reduced health costs
c) May provide a gateway/bridge into treatment
d) It's more palatable to clients than abstinence
e) Client choice
f) It's non-judgemental
g) It's client centred
h) It's appropriate for some clients
i) It's pragmatic/practical
j) It provides flexibility/options
k) It empowers the client
l) Don't know
m) Other
54. Most troubling aspects of harm reduction
a) It's not appropriate for or in the best interest of all cli-
ents
b) It's often misunderstood and misapplied
c) It creates moral and ethical dilemmas for the commu-
nity
d) It creates moral and ethical dilemmas for the therapist
e) Negative public attitudes
f) It's difficult to use illicit drugs safely
g) Abstinence is better
h) Harm reduction should be accompanied by counsel-
ling
i) Don't know
j) Other
55. On a scale from 0 to 10 with 0 = "not at all favorable"
and 10 = "extremely favorable," how would you feel
about helping some alcohol/drug abusers use substances
more safely without necessarily trying to reduce their use
of these substances?
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